Which screening strategy should be offered to women with BRCA1 or BRCA2 mutations? A simulation of comparative cost-effectiveness. (Q36889714)
Jump to navigation
Jump to search
scientific article published on 11 April 2013
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Which screening strategy should be offered to women with BRCA1 or BRCA2 mutations? A simulation of comparative cost-effectiveness. |
scientific article published on 11 April 2013 |
Statements
Which screening strategy should be offered to women with BRCA1 or BRCA2 mutations? A simulation of comparative cost-effectiveness (English)
K M Vermeulen
L Jansen
J C Oosterwijk
S Siesling
M D Dorrius
N Houssami
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference